Antibody Production and Purification Reagents and Kits
Cayman Chemical TCS 5861528, Purity: ≥98%, CAS: 332117-28-9, 5 mg
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx induced by allyl isothiocyanate and 4-hydroxy nonenal (IC50s = 14.3 and 18.7 μM, respectively); 30 mg/kg twice daily in rats attenuates pain-related behavior in models of diabetic hypersensitivity and postoperative pain
Cayman Chemical TCS PIM-1 1, Purity: ≥98%, CAS: 491871-58-0, 5 mg
An ATP-competitive Pim-1 kinase inhibitor (IC50 = 50 nM) that displays selectivity over the related kinases, Pim-2 and MEK1/2 (IC50s = >20 µM)
Cayman Chemical TCS ERK 11e, Purity: ≥98%, CAS: 896720-20-0, 25 mg
A selective inhibitor of ERK2 (Ki 50 = 48 nM)
Cayman Chemical TCS 5861528, Purity: ≥98%, CAS: 332117-28-9, 25 mg
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx induced by allyl isothiocyanate and 4-hydroxy nonenal (IC50s = 14.3 and 18.7 μM, respectively); 30 mg/kg twice daily in rats attenuates pain-related behavior in models of diabetic hypersensitivity and postoperative pain
Cayman Chemical TCS 46b, Purity: ≥98%, CAS: 302799-86-6, 10 mg
An antagonist of NR1A/2B subunit-containing NMDA receptors (IC50 = 0.0053 µM); selective for NMDA receptors containing NR1A/2B subunits over NMDA receptors containing NR1A/2A and NR1A/2C subunits (IC50s = 35 and >100 µM, respectively); inhibits L-DOPA-induced contralateral rotations in a rat model of 6-OHDA-induced Parkinson's disease at 10 mg/kg; has been radiolabeled and used as an NR1A/2B-selective PET radiotracer
Cayman Chemical TCS 46b, Purity: ≥98%, CAS: 302799-86-6, 50 mg
An antagonist of NR1A/2B subunit-containing NMDA receptors (IC50 = 0.0053 µM); selective for NMDA receptors containing NR1A/2B subunits over NMDA receptors containing NR1A/2A and NR1A/2C subunits (IC50s = 35 and >100 µM, respectively); inhibits L-DOPA-induced contralateral rotations in a rat model of 6-OHDA-induced Parkinson's disease at 10 mg/kg; has been radiolabeled and used as an NR1A/2B-selective PET radiotracer
Cayman Chemical TCS 46b, Purity: ≥98%, CAS: 302799-86-6, 5 mg
An antagonist of NR1A/2B subunit-containing NMDA receptors (IC50 = 0.0053 µM); selective for NMDA receptors containing NR1A/2B subunits over NMDA receptors containing NR1A/2A and NR1A/2C subunits (IC50s = 35 and >100 µM, respectively); inhibits L-DOPA-induced contralateral rotations in a rat model of 6-OHDA-induced Parkinson's disease at 10 mg/kg; has been radiolabeled and used as an NR1A/2B-selective PET radiotracer
Cayman Chemical TCS 5861528, Purity: ≥98%, CAS: 332117-28-9, 10 mg
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx induced by allyl isothiocyanate and 4-hydroxy nonenal (IC50s = 14.3 and 18.7 μM, respectively); 30 mg/kg twice daily in rats attenuates pain-related behavior in models of diabetic hypersensitivity and postoperative pain
Cayman Chemical TCS 5861528, Purity: ≥98%, CAS: 332117-28-9, 50 mg
A selective TRPA1 blocker that antagonizes TRPA1-mediated calcium influx induced by allyl isothiocyanate and 4-hydroxy nonenal (IC50s = 14.3 and 18.7 μM, respectively); 30 mg/kg twice daily in rats attenuates pain-related behavior in models of diabetic hypersensitivity and postoperative pain
Cayman Chemical TCS ERK 11e, Purity: ≥98%, CAS: 896720-20-0, 5 mg
A selective inhibitor of ERK2 (Ki 50 = 48 nM)
Cayman Chemical TCS 46b, Purity: ≥98%, CAS: 302799-86-6, 25 mg
An antagonist of NR1A/2B subunit-containing NMDA receptors (IC50 = 0.0053 µM); selective for NMDA receptors containing NR1A/2B subunits over NMDA receptors containing NR1A/2A and NR1A/2C subunits (IC50s = 35 and >100 µM, respectively); inhibits L-DOPA-induced contralateral rotations in a rat model of 6-OHDA-induced Parkinson's disease at 10 mg/kg; has been radiolabeled and used as an NR1A/2B-selective PET radiotracer
Cayman Chemical TCS ERK 11e, Purity: ≥98%, CAS: 896720-20-0, 1 mg
A selective inhibitor of ERK2 (Ki 50 = 48 nM)
Cayman Chemical TCS ERK 11e, Purity: ≥98%, CAS: 896720-20-0, 10 mg
A selective inhibitor of ERK2 (Ki 50 = 48 nM)